RedHill sees positive results for antiMAP Crohn's drug
Drug could be "paradigm shift" in $10 billion industry
View ArticleRedHill jumps on positive Phase III Crohn's Disease trial
The company will look for a partner to finance confirmatory Phase III trials of the product.
View ArticleStudy Supports Safety of Infliximab in Pregnancy
New registry data should help reassure women with Crohn's disease CD who need to continue infliximab during pregnancy that it won't harm their baby. Reuters Health Information
View ArticleProtein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H1 2018 Report...
Protein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H1 2018SummaryAccording to the recently published report 'Protein Phosphatase 2A PP2A or EC 3.1.3.16 Pipeline Review H1 2018'; Protein...
View ArticleTrivedi Global Inc. and Roland Piedad Announce Research on the Impact of a...
Overall immunity increased by over 250.LOS ANGELES PRWEB July 31 2018 Roland Piedad an evidencebased energy healer today announces research based on the impact of a biofield energy treated...
View ArticleRedHills RHB104 meets primary endpoint in phase III Crohns disease study
The company has announced the positive topline safety and efficacy results from the MAP US study which showed superiority of RHB104 over placebo. RHB104 is a proprietary and The post RedHills RHB104...
View ArticleIsraeli Crohns Disease Drug Rakes in Positive Phase III Results
RedHill Biopharma has obtained positive Phase III results for its Crohns disease treatment which targets a certain type of gut bacteria. Crohns disease is a type of inflammatory bowel disease...
View ArticlePioneering Crohns antibiotic treatment meets early target
A drug targeted at treating Crohns disease has shown promise following positive results in a phase 3 trial.RedHills drug RHB104 met its primary endpoint demonstrating a superior remission rate six...
View ArticleAbbVie Inc ABBV Medical Equipment Deals and Alliances Profile Report Updated...
SummaryAbbVie Inc AbbVie is a researchbased biopharmaceutical company that carries out the research development manufacture and commercialization of advanced therapies to treat complex and serious...
View ArticleGlobal Transfection Technologies Market 20182022 Rising Demand for Monoclonal...
Technavio analysts forecast the global transfection technologies market to grow at a CAGR of almost 9 during the forecast period according to their latest market research report. This press release...
View ArticleXELJANZÂ tofacitinib citrate Receives Marketing Authorization in the European...
Pfizer Inc. NYSEPFE announced today that the European Commission EC has approved XELJANZÂ tofacitinib citrate 10 mg twicedaily BID for at least eight weeks followed by XELJANZ 5 mg BID or 10 mg BID for...
View ArticleTrivedi Global Inc. and Roland Piedad Announce Research Results on the Impact...
40 decrease in expression of inflammatory biomarkers seen in the preclinical research. The preclinical research assessed biomarkers for systemic and organspecific inflammation as well as immune...
View ArticleArena Pharmaceuticals Inc ARNA Pharmaceuticals Healthcare Deals and Alliances...
SummaryArena Pharmaceuticals Inc Arena is a biopharmaceutical company which discovers develops and commercializes small molecule drugs in multiple therapy areas. It is evaluating its lead candidate...
View ArticleSoligenix Inc SNGX Pharmaceuticals Healthcare Deals and Alliances Profile...
SummarySoligenix Inc Soligenix is a latestage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures....
View ArticleNew Crohn Disease Management Guidelines Top Five Takeaways
Recently published guidelines by the American College of Gastroenterology provide recommendations on the management of Crohn disease. Dr David Johnson shares his perspective on some of the highlights....
View ArticleTiGenix NV TIG Medical Equipment Deals and Alliances Profile Report Updated...
SummaryTiGenix NV TiGenix is a biopharmaceutical company that develops and commercializes novel therapeutics. Its product portfolio includes AlloCSC01 AlloCSC02 Cx611 and Cx601. The company develops...
View ArticleCReactive Protein CRP Test
Source National Library of Medicine Related MedlinePlus Pages Arthritis Autoimmune Diseases Crohn's Disease Giant Cell Arteritis Infectious Arthritis Polymyalgia Rheumatica Rheumatoid Arthritis...
View Article